CervoMed Inc (NASDAQ: CRVO) on Tuesday, soared 6.31% from the previous trading day, before settling in for the closing price of $2.22. Within the past 52 weeks, CRVO’s price has moved between $1.80 and $26.38.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -127.35%. With a float of $5.35 million, this company’s outstanding shares have now reached $8.25 million.
The firm has a total of 8 workers. Let’s measure their productivity. In terms of profitability, gross margin is 30.24%, operating margin of -165.71%, and the pretax margin is -147.01%.
CervoMed Inc (CRVO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of CervoMed Inc is 35.20%, while institutional ownership is 18.00%. The most recent insider transaction that took place on Aug 27 ’24, was worth 18,160. In this transaction CFO & GC of this company bought 1,000 shares at a rate of $18.16, taking the stock ownership to the 1,267 shares.
CervoMed Inc (CRVO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -127.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.42% during the next five years compared to 73.43% growth over the previous five years of trading.
CervoMed Inc (NASDAQ: CRVO) Trading Performance Indicators
CervoMed Inc (CRVO) is currently performing well based on its current performance indicators. A quick ratio of 15.04 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.64, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -1.59 in one year’s time.
Technical Analysis of CervoMed Inc (CRVO)
Analysing the last 5-days average volume posted by the [CervoMed Inc, CRVO], we can find that recorded value of 0.3 million was better than the volume posted last year of 0.14 million. As of the previous 9 days, the stock’s Stochastic %D was 77.40%. Additionally, its Average True Range was 0.19.
During the past 100 days, CervoMed Inc’s (CRVO) raw stochastic average was set at 4.24%, which indicates a significant decrease from 96.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.93% in the past 14 days, which was lower than the 258.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.23, while its 200-day Moving Average is $11.08. Now, the first resistance to watch is $2.51. This is followed by the second major resistance level at $2.67. The third major resistance level sits at $2.96. If the price goes on to break the first support level at $2.06, it is likely to go to the next support level at $1.77. Now, if the price goes above the second support level, the third support stands at $1.61.
CervoMed Inc (NASDAQ: CRVO) Key Stats
Market capitalization of the company is 19.48 million based on 6,170K outstanding shares. Right now, sales total 7,140 K and income totals -2,170 K. The company made 1,940 K in profit during its latest quarter, and -4,750 K in sales during its previous quarter.
